Tolemy
2 known investors
Tolemy builds an AI-native virtual cell platform that models and directs cellular systems to support therapeutic development and manufacturing. It targets applications in cell biology, advanced therapeutics, and bioprocessing.
Investors · 2
Frequently asked questions
- What does Tolemy do?
- Tolemy builds an AI-native virtual cell platform that models and directs cellular systems to support therapeutic development and manufacturing. It targets applications in cell biology, advanced therapeutics, and bioprocessing.
- Who are Tolemy's investors?
- Tolemy's investors include Masia, Redbus Ventures.